Skip to main content
Premium Trial:

Request an Annual Quote

BioImage Signs Technology Licensing Deal with Merck

NEW YORK, Sept. 13 (GenomeWeb News) - BioImage said today that it has signed a deal granting Merck the right to use its Redistribution technology in drug discovery research.

 

According to BioImage, the Redistribution technology allows for high-throughput screening on a number of drug discovery live cell screening applications, including protein translocations, receptor internalizations, protein trafficking, and secretions.

 

Financial terms of the arrangement were not disclosed.

 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.